American Superconductor Receive $2m Grant to Help Commercialise HTS Technology

American Superconductor announced today that they have just received a cost sharing grant from the US Government’s Advanced Technology Program (ATP). The grant worth $2 million will be used to accelerate the scale up of their patented high volume, low cost manufacturing process for the production of high temperature superconducting (HTS) wires.

Work will be focussed on the development and implementation of novel thermal processing equipment, that is expected to bring about further performance gains for the high temperature superconducting wires with coated conductor wire architecture.

The process used to produce the coated conductor HTS wires requires lower capital expenditure compared to competing technologies. The process itself integrates aspects such as manufacturing process control, cleanliness of semiconductor fabrication and reel-to-reel web handling, with the speed of production of textile manufacture, at the temperatures of optical fibre synthesis.

American Superconductor have been developing the coated conductor HTS wires for the last seven years. However, during the last quarter, they have achieved results that indicate that they can exceed the price/performance ratio of conventional copper wires. This could result in the commercial acceptance of HTS wires in the marketplace sooner than was previously expected.

American Superconductor expect to have long lengths of the coated conductor HTS wires available in limited volumes by 2005. These will go some way to replacing their existing multi-filamentary composite wires, currently in use. The coated conductor wires offer improved performance at a significantly reduced cost compared to existing materials.

For more information on superconductors, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.